Case Report: Autoimmune cerebellar ataxia with anti-neurochondrin antibodies following herpes simplex virus encephalitis: two cases and literature review

Background Autoimmune cerebellar ataxia (ACA) secondary to viral encephalitis is rarely reported. We describe two middle-aged male patients who developed primary autoimmune cerebellar ataxia (PACA) with serum- and cerebrospinal fluid (CSF)-positive anti-neurochondrin–eurochondrini-ne (NCDN-IgG) 5–8 weeks after recovery from herpesvirus encephalitis, alongside a systematic literature review. Methods We prospectively collected the clinical manifestations, laboratory findings, neuroimaging features, treatment regimens, and long-term follow-up data of the two enrolled patients. Metagenomic next-generation sequencing (mNGS) was performed on the CSF and peripheral blood for pathogen detection. Neural autoantibodies were screened using combined cell-based assay (CBA) and tissue-based assay (TBA). Results Both patients achieved full recovery from human herpesvirus 4 and human herpesvirus 6 encephalitis after standardized 3 weeks antiviral therapy. Following hospital discharge, both developed subacute pancerebellar syndromes manifesting as gait instability, dysarthria, and limb dysmetria. Brain magnetic resonance imaging demonstrated no cerebellar atrophy or focal parenchymal lesions. The serum and CSF NCDN-IgG were both positive at a titer of 1:100, whereas other cerebellitis-related autoantibodies were negative. Both patients received combined intravenous methylprednisolone pulse therapy plus intravenous immunoglobulin (IVIG), followed by tapering oral corticosteroids. Neurological function improved gradually, and both regained independent ambulation within 3 months. Whole-body 18 F-FDG PET-CT excluded underlying malignancy in both individuals. Conclusions Our observations showed a temporal association between the preceding herpesvirus family encephalitis and the subsequent anti-NCDN-mediated PACA, although causality cannot be established from this two-case series. Clinicians may consider NCDN-IgG testing for patients presenting with new-onset subacute cerebellar dysfunction after viral encephalitis, particularly when routine cerebellar autoantibody panels yield negative results. Early combined immunomodulatory therapy may facilitate neurological recovery. Larger prospective cohorts are required to validate our findings.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-19
DOI
https://doi.org/10.3389/fimmu.2026.1954841
Primary Topic
Autoimmune Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Case Report: Autoimmune cerebellar ataxia with anti-neurochondrin antibodies following herpes simplex virus encephalitis: two cases and literature review

贾延劼, Xinxin Wang, Qinchen Cao, Ruifang Wang
Frontiers in Immunology
Autoimmune Neurological Disorders and Treatments
article

Case Report: Autoimmune cerebellar ataxia with anti-neurochondrin antibodies following herpes simplex virus encephalitis: two cases and literature review

贾延劼, Xinxin Wang, Qinchen Cao, Ruifang Wang
article en

Abstract

Background Autoimmune cerebellar ataxia (ACA) secondary to viral encephalitis is rarely reported. We describe two middle-aged male patients who developed primary autoimmune cerebellar ataxia (PACA) with serum- and cerebrospinal fluid (CSF)-positive anti-neurochondrin–eurochondrini-ne (NCDN-IgG) 5–8 weeks after recovery from herpesvirus encephalitis, alongside a systematic literature review. Methods We prospectively collected the clinical manifestations, laboratory findings, neuroimaging features, treatment regimens, and long-term follow-up data of the two enrolled patients. Metagenomic next-generation sequencing (mNGS) was performed on the CSF and peripheral blood for pathogen detection. Neural autoantibodies were screened using combined cell-based assay (CBA) and tissue-based assay (TBA). Results Both patients achieved full recovery from human herpesvirus 4 and human herpesvirus 6 encephalitis after standardized 3 weeks antiviral therapy. Following hospital discharge, both developed subacute pancerebellar syndromes manifesting as gait instability, dysarthria, and limb dysmetria. Brain magnetic resonance imaging demonstrated no cerebellar atrophy or focal parenchymal lesions. The serum and CSF NCDN-IgG were both positive at a titer of 1:100, whereas other cerebellitis-related autoantibodies were negative. Both patients received combined intravenous methylprednisolone pulse therapy plus intravenous immunoglobulin (IVIG), followed by tapering oral corticosteroids. Neurological function improved gradually, and both regained independent ambulation within 3 months. Whole-body 18 F-FDG PET-CT excluded underlying malignancy in both individuals. Conclusions Our observations showed a temporal association between the preceding herpesvirus family encephalitis and the subsequent anti-NCDN-mediated PACA, although causality cannot be established from this two-case series. Clinicians may consider NCDN-IgG testing for patients presenting with new-onset subacute cerebellar dysfunction after viral encephalitis, particularly when routine cerebellar autoantibody panels yield negative results. Early combined immunomodulatory therapy may facilitate neurological recovery. Larger prospective cohorts are required to validate our findings.

Frontiers in ImmunologyVol. 17
First Affiliated Hospital of Zhengzhou University (CN)
Autoimmune Neurological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon